{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:41:49Z","timestamp":1791333709304,"version":"4.3.1"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,9,8]]},"DOI":"10.1001\/jama.2020.15543","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:29:27Z","timestamp":1597379367000},"page":"951","source":"Crossref","is-referenced-by-count":702,"title":["Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes"],"prefix":"10.1001","volume":"324","author":[{"given":"Shengli","family":"Xia","sequence":"first","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Duan","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Zhang","sequence":"additional","affiliation":[{"name":"China National Biotec Group Company Limited, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguo","family":"Li","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (Incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkai","family":"Yang","sequence":"additional","affiliation":[{"name":"China National Biotec Group Company Limited, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Gao","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangyang","family":"You","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Wang","sequence":"additional","affiliation":[{"name":"China National Biotec Group Company Limited, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Wang","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Shi","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqin","family":"Yang","sequence":"additional","affiliation":[{"name":"China National Biotec Group Company Limited, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghao","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Huang","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"China National Biotec Group Company Limited, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wu","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wang","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihe","family":"Huang","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Du","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Meng","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Ministry of Education Key Laboratory of Environment and Health and State Key Laboratory of Environmental Health (Incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"},{"name":"National Medical Center for Major Public Health Events, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Yuan","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Shen","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanshen","family":"Guo","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yang","sequence":"additional","affiliation":[{"name":"National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co Ltd, Wuhan, Hubei, China"},{"name":"China National Biotec Group Company Limited, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10240","key":"jpc200005r3","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"jpc200005r4","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.","author":"Zhu","journal-title":"Lancet"},{"key":"jpc200005r7","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report.","author":"Jackson","journal-title":"N Engl J Med"},{"key":"jpc200005r8","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial.","author":"Folegatti","journal-title":"Lancet"},{"issue":"1","key":"jpc200005r9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.anai.2020.01.025","article-title":"Key steps in vaccine development.","volume":"125","author":"Stern","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6499","key":"jpc200005r10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2.","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"jpc200005r11","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2.","author":"Wang","journal-title":"Cell"},{"issue":"17","key":"jpc200005r12","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients.","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"jpc200005r13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19.","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"jpc200005r15","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals.","author":"Robbiani","journal-title":"Nature"},{"key":"jpc200005r16","article-title":"Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients.","author":"Wang","journal-title":"Clin Infect Dis"},{"key":"jpc200005r18","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.","author":"Zhao","journal-title":"Clin Infect Dis"},{"key":"jpc200005r20","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.","author":"Long","journal-title":"Nat Med"},{"key":"jpc200005r21","article-title":"Rapid decay of anti\u2013SARS-CoV-2 antibodies in persons with mild Covid-19.","author":"Ibarrondo","journal-title":"N Engl J Med"},{"issue":"11","key":"jpc200005r22","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1056\/NEJMc070348","article-title":"Disappearance of antibodies to SARS-associated coronavirus after recovery.","volume":"357","author":"Cao","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"jpc200005r23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir Ther"},{"issue":"50","key":"jpc200005r24","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a phase I clinical trial.","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"jpc200005r25","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.","author":"Le Bert","journal-title":"Nature"},{"issue":"7","key":"jpc200005r26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41587-020-0577-1","article-title":"Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.","volume":"38","author":"Eroshenko","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"6494","key":"jpc200005r27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development.","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"jpc200005r28","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.","author":"Corbett","journal-title":"N Engl J Med"},{"key":"jpc200005r29","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques.","author":"Chandrashekar","journal-title":"Science"},{"key":"jpc200005r30","article-title":"Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.","author":"Deng","journal-title":"Science"},{"issue":"12","key":"jpc200005r31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jama.1967.03130250057008","article-title":"Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccines.","volume":"202","author":"Fulginiti","year":"1967","journal-title":"JAMA"},{"issue":"4","key":"jpc200005r32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"6","key":"jpc200005r33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-0323-4","article-title":"COVID-19 vaccine design: the Janus face of immune enhancement.","volume":"20","author":"Hotez","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"jpc200005r34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41577-020-0358-6","article-title":"COVID-19 vaccines: neutralizing antibodies and the alum advantage.","volume":"20","author":"Hotez","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"jpc200005r5","author":"Sahin","year":"2020"},{"key":"jpc200005r6","author":"Mulligan","year":"2020"},{"key":"jpc200005r14","author":"Luchsinger","year":"2020"},{"key":"jpc200005r17","author":"Wu","year":"2020"},{"key":"jpc200005r19","author":"Liu","year":"2020"},{"key":"jpc200005r1","unstructured":"World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Accessed July 30, 2020. https:\/\/covid19.who.int\/"},{"key":"jpc200005r2","unstructured":"World Health Organization. Draft landscape of COVID-19 candidate vaccines. Accessed July 30, 2020. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2769612\/jama_xia_2020_pc_200005_1599242849.34452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T22:25:38Z","timestamp":1667773538000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2769612"}},"subtitle":["Interim Analysis of 2 Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9,8]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.15543","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,8]]}}}